Rep. Kevin Hern (R-OK) Sells MRSH Stock
Oklahoma Congressman Kevin Hern sold shares of Marsh & McLennan valued between $50,001 and $100,000.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Kevin Hern (R-OK) sold between $50,001 and $100,000 of Marsh & McLennan Companies, Inc. ($MRSH) stock on September 17, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed October 13, 2026.
Since the trade, $MRSH is down 2.7% after 1 week and up 8.5% to date (from the $173.57 close on Sep 17, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Kevin Hern (R-OK)
- Status:
- Member — House
- State/District:
- OK-1
- Party:
- Republican
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Oct 13, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Marsh & McLennan Companies, Inc. ($MRSH) | Sell | Sep 17, 2026 | $50,001 - $100,000 |
Summary of the filed report, not the original document. View the original: STOCK Act disclosure (House Clerk)
Key Points
- On September 17, 2026, Congressman Kevin Hern sold shares of Marsh & McLennan valued between $50,001 and $100,000.
- As of October 16, 2026, Marsh & McLennan traded recently around $188.36, which is above its 50-day moving average by about 3.9%.
- The company has a dividend yield of 2.12% and is expected to report earnings on January 28, 2027.
Get $MRSH trade alerts by text
We text you when insiders, Congress or big funds trade $MRSH. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Marsh & McLennan Companies, Inc. alert may contain errors. Disclosures
Oklahoma Congressman Kevin Hern sold shares of Marsh & McLennan Companies, Inc. (MRSH) on September 17, 2026. The transaction was valued between $50,001 and $100,000, as reported in a periodic transaction report filed under the STOCK Act on October 13, 2026.
Kevin Hern vs. the S&P 500
Hypothetical returns from Kevin Hern's disclosed trades, not real profit or advice. How we model this.
Inside Kevin Hern's Trade
Hern's recent sale was part of his ongoing adjustments to his investment portfolio. This transaction comes after he sold shares of other companies, including TJX Companies and Starbucks, earlier in September.
Other Institutional Activity in Marsh & McLennan
Several other institutional investors have been active with Marsh & McLennan. Blackrock Inc. reduced its holdings by 2,561,681 shares, now owning 39,502,046 shares valued at about $7.44 billion. Vanguard Capital Management LLC added 6,293 shares, bringing its total to 31,472,575 shares worth approximately $5.93 billion. State Street Corporation increased its stake by 331,059 shares, resulting in a total of 22,401,676 shares valued at around $4.22 billion.
Marsh & McLennan Companies, Inc. Stock Up 1.0%
As of October 16, 2026, Marsh & McLennan shares were recently trading at $188.36. This price is above its 50-day moving average of $181.38 and its 200-day average of $176.70. However, it is about 5.1% below its 52-week high of $198.49.
Recent Earnings
In its latest earnings report, Marsh & McLennan posted a trailing twelve-month revenue of approximately $28.46 billion and an EPS of $8.18. The company's revenue growth year-over-year stands at 8.1%, with a net margin of 14.2%. The next earnings date is set for January 28, 2027.
Insider Buying and Selling at Marsh & McLennan Companies, Inc.
Several insiders have also sold shares recently. Chief Executive Officer John Q. Doyle sold 16,656 shares on September 2, 2026, valued at about $3.14 million. Other insiders, including Chief Technology Officer Paul Beswick and Officer John Jude Jones, also sold shares during the past few months.
Analysts Set New Price Targets
Analysts have maintained various ratings for Marsh & McLennan recently. On October 1, 2026, JP Morgan maintained an Overweight rating with a price target of $215. Earlier, Morgan Stanley had an Equal-Weight rating with a target of $200. The consensus recommendation for the stock remains a "hold," with a mean target price of about $202.52.
About Marsh & McLennan
Marsh & McLennan Companies, Inc. provides advisory services and insurance solutions, operating in the financial services sector. The company helps clients manage risk and develop strategies through its Risk and Insurance Services and Consulting segments. This activity is particularly relevant to Hern's district, where financial services play a key role in the local economy.
Bottom Line
Kevin Hern's recent sale of Marsh & McLennan shares adds to his series of transactions in September. Investors should keep an eye on the upcoming earnings report on January 28, 2027, as well as any further stock transactions by Hern as he continues to adjust his portfolio.
Source: Kevin Hern's STOCK Act disclosure on $MRSH (Sep 17, 2026). Read the original filing: STOCK Act disclosure (House Clerk). Written by software, not financial advice. How we make alerts
